One theranostic partner for 68Ga-PSMA is 177Lu-PSMA-617, a beta-emitting compound containing lutetium that similarly uses PSMA as its target molecule, delivering radiation to the PSMA-expressing tumor cells [25]. This evidence concerns the gene FOLH1 and neoplasm.